Yu De-Chao
$985.41M
as of 11/23/21
About Yu De-Chao
Yu De-Chao, also known as Michael Yu, is the chairman and CEO of Innovent Biologics, a China-headquartered biotech company.
Innovent went public at the Hong Kong Stock Exchange in 2018.
Yu holds a PhD in molecular genetics from the Chinese Academy of Sciences.
Yu had a postdoc position in pharmaceutical chemistry at the University of California San Francisco in 1993-1996.
Yu had a postdoc position in pharmaceutical chemistry at the University of California, San Francisco in 1993-1996.
Personal stats
Citizenship
United States of AmericaSource of wealth
pharmaceuticalsResidence
Suzhou, People's Republic of ChinaBirth date
01/01/64 (age 60)Education
Ph.D, Chinese Academy of SciencesSelf-made
self-madeYu De-Chao’s fortune is worth
16K
troy ounces of gold
15K
median U.S. household
10K
median U.S. income
0.02%
U.S. credit card volume
0.004%
GDP of the United States
0.003%
United States debt
Net worth history
Annual ranking
Net worth over time
Real-time ranking
Financial assets
HONG KONG | 1801-HK
Innovent BiologicsImages © Forbes.com. All rights reserved.